Literature DB >> 12096347

Frequent mutations of Fas gene in nasal NK/T cell lymphoma.

Tetsuya Takakuwa1, Zhiming Dong, Shinichi Nakatsuka, Shizuo Kojya, Yasuaki Harabuchi, Woo-Ick Yang, Shigekazu Nagata, Katsuyuki Aozasa.   

Abstract

Fas (Apo-1/CD95) is a cell-surface receptor involved in cell death signaling through binding of Fas ligand. Mutation of Fas gene in lymphoid cells results in accumulation of these cells, which might thus contribute to lymphomagenesis. We examined the open reading frame of Fas cDNA in 14 cases of nasal NK/T-cell lymphoma. Mutations of Fas gene were detected in seven (50%) of 14 cases which comprised four frameshift, two missense, and one silent mutations. Frameshift mutations were caused by insertion of 1 bp (A) at nucleotide 1095 in two cases and by deletion of 1 bp at nucleotide 597 and at 704, respectively, in one each. Mouse T-cell lymphoma cells transfected with two missense mutated genes and frameshift mutations caused by insertion of 1 bp (A) at nucleotide 1095 were resistant to apoptosis induced by the anti-Fas antibody. These findings suggested that accumulation of lymphoid cells with Fas mutations provides a basis for the development of nasal NK/T-cell lymphoma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12096347     DOI: 10.1038/sj.onc.1205571

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  23 in total

1.  Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.

Authors:  Can Küçük; Bei Jiang; Xiaozhou Hu; Wenyan Zhang; John K C Chan; Wenming Xiao; Nathan Lack; Can Alkan; John C Williams; Kendra N Avery; Pınar Kavak; Anna Scuto; Emel Sen; Philippe Gaulard; Lou Staudt; Javeed Iqbal; Weiwei Zhang; Adam Cornish; Qiang Gong; Qunpei Yang; Hong Sun; Francesco d'Amore; Sirpa Leppä; Weiping Liu; Kai Fu; Laurence de Leval; Timothy McKeithan; Wing C Chan
Journal:  Nat Commun       Date:  2015-01-14       Impact factor: 14.919

Review 2.  CD95-mediated cell signaling in cancer: mutations and post-translational modulations.

Authors:  Sébastien Tauzin; Laure Debure; Jean-François Moreau; Patrick Legembre
Journal:  Cell Mol Life Sci       Date:  2011-11-01       Impact factor: 9.261

Review 3.  Natural killer cell neoplasm: biology and pathology.

Authors:  Maria Francisca Ham; Young-Hyeh Ko
Journal:  Int J Hematol       Date:  2010-12-07       Impact factor: 2.490

4.  Over-expressed Fas improves the apoptosis of malignant T-cells in vitro and vivo.

Authors:  Linghao Li; Ri Zhang; Zixing Chen; Shengli Xue; Xiuli Wang; Changgeng Ruan
Journal:  Mol Biol Rep       Date:  2011-03-11       Impact factor: 2.316

Review 5.  Nasal natural killer (NK)/T-cell lymphoma: clinical, histological, virological, and genetic features.

Authors:  Yasuaki Harabuchi; Miki Takahara; Kan Kishibe; Shigetaka Moriai; Toshihiro Nagato; Hideyuki Ishii
Journal:  Int J Clin Oncol       Date:  2009-07-11       Impact factor: 3.402

6.  Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type.

Authors:  Yenlin Huang; Aurélien de Reyniès; Laurence de Leval; Bouchra Ghazi; Nadine Martin-Garcia; Marion Travert; Jacques Bosq; Josette Brière; Barbara Petit; Emilie Thomas; Paul Coppo; Teresa Marafioti; Jean-François Emile; Marie-Hélène Delfau-Larue; Christian Schmitt; Philippe Gaulard
Journal:  Blood       Date:  2009-11-30       Impact factor: 22.113

7.  JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma.

Authors:  A Bouchekioua; L Scourzic; O de Wever; Y Zhang; P Cervera; A Aline-Fardin; T Mercher; P Gaulard; R Nyga; D Jeziorowska; L Douay; W Vainchenker; F Louache; C Gespach; E Solary; P Coppo
Journal:  Leukemia       Date:  2013-05-21       Impact factor: 11.528

8.  STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma.

Authors:  P Coppo; V Gouilleux-Gruart; Y Huang; H Bouhlal; H Bouamar; S Bouchet; C Perrot; V Vieillard; P Dartigues; P Gaulard; F Agbalika; L Douay; K Lassoued; N-C Gorin
Journal:  Leukemia       Date:  2009-05-07       Impact factor: 11.528

Review 9.  Molecular Pathogenesis of Peripheral T Cell Lymphoma.

Authors:  Mamiko Sakata-Yanagimoto; Shigeru Chiba
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 4.213

Review 10.  Extranodal NK/T-cell lymphoma: toward the identification of clinical molecular targets.

Authors:  Christian Schmitt; Nouhoum Sako; Martine Bagot; Yenlin Huang; Philippe Gaulard; Armand Bensussan
Journal:  J Biomed Biotechnol       Date:  2011-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.